...
机译:具有激活识别的双靶向脂质体,用于三重阴性乳腺癌的粘液(5)和α(v)β(3)
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Sichuan Univ Sichuan Res Ctr Drug Precis Ind Technol Sichuan Engn Lab Plant Sourced Drug West;
Liposome; Dual-targeting; TNBC; Fructose; RGD peptide;
机译:具有激活识别的双靶向脂质体,用于三重阴性乳腺癌的粘液(5)和α(v)β(3)
机译:整联蛋白alpha(v)beta(3-5)配体MFG-E8是三阴性乳腺癌中的p63 / p73目标基因,但在ER(+)和erbB2(+)乳腺癌中表现出抑制功能。
机译:葡萄糖转运蛋白GLUT-1和雌激素受体ER-alpha和ER-beta在人乳腺癌中的表达。
机译:CD151,整合素α3β1和MMP7在乳腺癌组织微阵列中的表达及其临床病理意义
机译:三重阴性乳腺癌中孤儿核受体雌激素相关的受体β
机译:Aurora-A / ERK1 / 2 / mTOR轴促进三阴性乳腺癌中的肿瘤进展双重靶向Aurora-A / mTOR显示出合成杀伤力
机译:α v sub>β 3 sub>整合蛋白靶向胶束Mertansine前药有效地抑制了体内三阴性乳腺癌